Journal of Medical Ethics 38 (10):626-629 (2012)
AbstractIt is widely agreed that medical researchers who conduct studies in low- and middle-income countries (LMICs) are morally required to ensure that their research benefits the broader host community, not only the subjects. The justification for this moral requirement has not been adequately examined. Most attempts to justify this requirement focus on researchers' interaction with the community as a whole, not on their relationship with their subjects. This paper argues that in some cases, research must benefit the broader host community for researchers to treat subjects and prospective subjects ethically. If research presents substantial net risks to subjects, researchers can ethically ask LMIC citizens to participate only if people in LMICs, normally including people in the host community, stand to benefit.
Added to PP
Historical graph of downloads
References found in this work
An Egalitarian Law of Peoples.Thomas W. Pogge - 1994 - Philosophy and Public Affairs 23 (3):195-224.
Rethinking the Ethics of Clinical Research: Widening the Lens.Alan Wertheimer - 2010 - Oxford University Press.
Justice and the Human Development Approach to International Research.Alex John London - 2005 - Hastings Center Report 35 (1):24-37.
Justice and the Human Development Approach to International Research.Alex John London - 2005 - Hastings Center Report 35 (1):24.
Citations of this work
Meeting the Needs of Underserved Populations: Setting the Agenda for More Inclusive Citizen Science of Medicine.Amelia Fiske, Barbara Prainsack & Alena Buyx - 2019 - Journal of Medical Ethics 45 (9):617-622.
Canadian Research Ethics Board Members’ Attitudes Toward Benefits From Clinical Trials.Kori Cook, Jeremy Snyder & John Calvert - 2015 - BMC Medical Ethics 16 (1):1-7.
Similar books and articles
Justifying Community Benefit Requirements in International Research.Robert C. Hughes - 2014 - Bioethics 28 (8):397-404.
Research Involving Prisoners: Consensus and Controversies in International and European Regulations.Bernice S. Elger - 2008 - Bioethics 22 (4):224–238.
Making Risk-Benefit Assessments of Medical Research Protocols.Alex Rajczi - 2004 - Journal of Law, Medicine and Ethics 32 (2):338-348.
Understanding Risks and Benefits in Research on Reproductive Genetic Technologies.Janet Malek - 2007 - Journal of Medicine and Philosophy 32 (4):339 – 358.
On the Limits of Parental Proxy Consent: Children's Right to Non-Participation in Non-Therapeutic Research. [REVIEW]Sonja Grover - 2003 - Journal of Academic Ethics 1 (4):349-383.
The Harm-Benefit Tradeoff in "Bad Deal" Trials.Gillian Nycum & Lynette Reid - 2007 - Kennedy Institute of Ethics Journal 17 (4):321-350.
Xenotransplantation, Consent and International Justice.Robert Sparrow - 2009 - Developing World Bioethics 9 (3):119-127.
Ethical Aspects of Vulnerability in Research.Elisabeth Weisser-Lohmann - 2012 - Poiesis and Praxis 9 (1-2):157-162.
Does Community and Environmental Responsibility Affect Firm Risk? Evidence From UK Panel Data 1994–2006.A. Salama, K. Anderson & J. S. Toms - 2011 - Business Ethics, the Environment and Responsibility 20 (2):192-204.
The Michigan BioTrust for Health: Using Dried Bloodspots for Research to Benefit the Community While Respecting the Individual.Denise Chrysler, Harry McGee, Janice Bach, Ed Goldman & Peter D. Jacobson - 2011 - Journal of Law, Medicine and Ethics 39 (s1):98-101.
Return of Research Results: General Principles and International Perspectives.Emmanuelle Lévesque, Yann Joly & Jacques Simard - 2011 - Journal of Law, Medicine and Ethics 39 (4):583-592.